Medical Aesthetics Market by Product (Botox, Filler, Peel, Implant, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Nonsurgical), End User (Hospital, Beauty Clinic, Spa), Region - Global Forecast to 2030
“The global medical aesthetics market is estimated to reach USD 35.32 Billion by 2030 from USD 17.16 million in 2024, at a CAGR of 12.8% during the forecast period).”
The growth of the market of medical aesthetics is very high due to several factors. First, from the demand side, minimally invasive and non-invasive treatments are increasingly demanded since they have several advantages over conventional methods, such as a decreased risk of side effects and minimum recovery periods. Advances in aesthetic technologies, including multifunctional lasers and various skin rejuvenation techniques, enhance the effectiveness and precision of these treatments with better results that would benefit more people and make them more accessible and appealing to a larger market. The market for aesthetic procedures has been eased by increased disposable incomes in the developing world. Growing emphasis on wellness, self-care, and social media has increased demand as people seek beauty treatments to stay youthful. Other drivers include an aging population in developed countries looking for anti-aging solutions to a variety of problems. These factors are all contributing to the rise in the medical aesthetics market.
“The facial aesthetic products segment held the largest share of the market in 2023.”
The market for medical aesthetics captured the largest share of facial aesthetic products in 2023. This segment deals with facial aesthetic products, cosmetic implants, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals, skin lighteners, thread lift products, hair removal devices, tattoo removal devices, physician-dispensed eyelash products, and nail treatment laser devices. The major portion of facial aesthetic products accounts for non-invasive treatments for facial rejuvenation, such as Botox and dermal fillers. These products are preferred more because of their ability to deliver effective results with minimal downtime in a natural appearance. The market will also experience further growth because of the rising demand for aesthetic procedures that can be done at home. This shift toward at-home treatments, enabled by the availability of advanced, user-friendly devices, is contributing to the growing accessibility and affordability of facial aesthetic solutions. As a result, the facial aesthetic products segment shall remain on track to advance at the highest rate, following consumer preference for convenient and effective aesthetic enhancements.
“The lipolysis segment is projected to register the highest CAGR of the non-surgical procedures by procedure during the forecast period.”
The medical aesthetics market is segmented into surgical and nonsurgical procedures. Surgical procedures account for areas of breast augmentation, rhinoplasty, facelifts, body lifts, etc, while non-surgical procedures include anti-aging and skin rejuvenation, tattoo and scar removal, hair removal, lipolysis, and many others. Among these, the lipolysis segment is anticipated to record the highest compound annual growth rate (CAGR) within the non-surgical procedures market from 2024 to 2030. Lipolysis is a non-invasive technique for reducing excess fat that is gaining immense popularity due to its ability to target particular fat deposits without surgery. Consumer spending on cosmetic treatments, especially those that will help achieve body contouring, leads to the rapid growth of this segment. This is because numerous people are opting for more affordable and effective alternatives to traditional surgery. With lipolysis now available in the market, the development of advanced devices that allow for the precise extraction of fats with minimal downtime is further enhancing the demand. An increase in body consciousness with an increased awareness of non-surgical fat-reduction options contributes to the growth of the segment. The lipolysis segment is expected to experience continued growth and remain a key player in the medical aesthetics market across the forecast period as consumers remain focused on swift, efficient, and minimally invasive treatment options
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The Asia Pacific (APAC) region is anticipated to be the fastest-growing medical aesthetics market over the forecast period, mainly due to the rapid development of healthcare infrastructure, more so in emerging economies such as India and China. Moreover, investment in the respective healthcare sectors of these countries fosters the demand for advanced medical aesthetic systems, including dermatology, body contouring, and facial aesthetics. Additionally, increasing disposable incomes and the fast-expanding middle class in the region are further fueling demand for aesthetic treatments since it's a move toward skin rejuvenation, anti-aging, and cosmetic procedures.
The industry has seen the APAC region become a more significant area of interest for companies involved in medical aesthetics, where there has been an increasing focus on innovative products offered to consumers' changing preferences. Increased clinic, hospital, and medical spa coverage in the region is the accelerator for the adoption of these technologies. Increased awareness and acceptance of aesthetic treatments are expected to fuel the growth of the market soon. The APAC region is very poised to lead the medical aesthetics market with the rising healthcare infrastructure and has numerous opportunities for growth and expansion in the sector.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This market is segmented by product, application, end-user, and region. The report discusses drivers, restraints, opportunities, and challenges affecting the medical aesthetic market. It provides the prospects of opportunities and challenges for the stakeholders, along with detailing the competitive landscape of leading players. The micro-markets are further segmented focusing on growth trends, prospects, and the contributions of these trends towards the medical aesthetic market. To this, revenue generation through different market segments shall be forecasted and their respective growth focus put together based on five major geographies.
Key Benefits of Buying this Report
This report is to be profited by new and existing players. It will provide deep information about the medical aesthetic market for them to understand any investment opportunities. The present report provides complete information on the key players and minor players. Hence, this supports effective risk analysis along with informed decisions about investment. Due to the accurate segmentation based on end-users and geographies, this report gives niche-level views of the selected market areas.
Through this report, readers get insightful views into the following parameters:
The growth of the market of medical aesthetics is very high due to several factors. First, from the demand side, minimally invasive and non-invasive treatments are increasingly demanded since they have several advantages over conventional methods, such as a decreased risk of side effects and minimum recovery periods. Advances in aesthetic technologies, including multifunctional lasers and various skin rejuvenation techniques, enhance the effectiveness and precision of these treatments with better results that would benefit more people and make them more accessible and appealing to a larger market. The market for aesthetic procedures has been eased by increased disposable incomes in the developing world. Growing emphasis on wellness, self-care, and social media has increased demand as people seek beauty treatments to stay youthful. Other drivers include an aging population in developed countries looking for anti-aging solutions to a variety of problems. These factors are all contributing to the rise in the medical aesthetics market.
“The facial aesthetic products segment held the largest share of the market in 2023.”
The market for medical aesthetics captured the largest share of facial aesthetic products in 2023. This segment deals with facial aesthetic products, cosmetic implants, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals, skin lighteners, thread lift products, hair removal devices, tattoo removal devices, physician-dispensed eyelash products, and nail treatment laser devices. The major portion of facial aesthetic products accounts for non-invasive treatments for facial rejuvenation, such as Botox and dermal fillers. These products are preferred more because of their ability to deliver effective results with minimal downtime in a natural appearance. The market will also experience further growth because of the rising demand for aesthetic procedures that can be done at home. This shift toward at-home treatments, enabled by the availability of advanced, user-friendly devices, is contributing to the growing accessibility and affordability of facial aesthetic solutions. As a result, the facial aesthetic products segment shall remain on track to advance at the highest rate, following consumer preference for convenient and effective aesthetic enhancements.
“The lipolysis segment is projected to register the highest CAGR of the non-surgical procedures by procedure during the forecast period.”
The medical aesthetics market is segmented into surgical and nonsurgical procedures. Surgical procedures account for areas of breast augmentation, rhinoplasty, facelifts, body lifts, etc, while non-surgical procedures include anti-aging and skin rejuvenation, tattoo and scar removal, hair removal, lipolysis, and many others. Among these, the lipolysis segment is anticipated to record the highest compound annual growth rate (CAGR) within the non-surgical procedures market from 2024 to 2030. Lipolysis is a non-invasive technique for reducing excess fat that is gaining immense popularity due to its ability to target particular fat deposits without surgery. Consumer spending on cosmetic treatments, especially those that will help achieve body contouring, leads to the rapid growth of this segment. This is because numerous people are opting for more affordable and effective alternatives to traditional surgery. With lipolysis now available in the market, the development of advanced devices that allow for the precise extraction of fats with minimal downtime is further enhancing the demand. An increase in body consciousness with an increased awareness of non-surgical fat-reduction options contributes to the growth of the segment. The lipolysis segment is expected to experience continued growth and remain a key player in the medical aesthetics market across the forecast period as consumers remain focused on swift, efficient, and minimally invasive treatment options
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The Asia Pacific (APAC) region is anticipated to be the fastest-growing medical aesthetics market over the forecast period, mainly due to the rapid development of healthcare infrastructure, more so in emerging economies such as India and China. Moreover, investment in the respective healthcare sectors of these countries fosters the demand for advanced medical aesthetic systems, including dermatology, body contouring, and facial aesthetics. Additionally, increasing disposable incomes and the fast-expanding middle class in the region are further fueling demand for aesthetic treatments since it's a move toward skin rejuvenation, anti-aging, and cosmetic procedures.
The industry has seen the APAC region become a more significant area of interest for companies involved in medical aesthetics, where there has been an increasing focus on innovative products offered to consumers' changing preferences. Increased clinic, hospital, and medical spa coverage in the region is the accelerator for the adoption of these technologies. Increased awareness and acceptance of aesthetic treatments are expected to fuel the growth of the market soon. The APAC region is very poised to lead the medical aesthetics market with the rising healthcare infrastructure and has numerous opportunities for growth and expansion in the sector.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation: Director-level–25%, C-level–35%, and Others–40%
- By Region: North America–40%, Europe–30%, Asia Pacific–20%, Latin America-5%, Middle East and Africa-5%
Research Coverage
This market is segmented by product, application, end-user, and region. The report discusses drivers, restraints, opportunities, and challenges affecting the medical aesthetic market. It provides the prospects of opportunities and challenges for the stakeholders, along with detailing the competitive landscape of leading players. The micro-markets are further segmented focusing on growth trends, prospects, and the contributions of these trends towards the medical aesthetic market. To this, revenue generation through different market segments shall be forecasted and their respective growth focus put together based on five major geographies.
Key Benefits of Buying this Report
This report is to be profited by new and existing players. It will provide deep information about the medical aesthetic market for them to understand any investment opportunities. The present report provides complete information on the key players and minor players. Hence, this supports effective risk analysis along with informed decisions about investment. Due to the accurate segmentation based on end-users and geographies, this report gives niche-level views of the selected market areas.
Through this report, readers get insightful views into the following parameters:
- Analysis of the key growth drivers, restraints, challenges, and opportunities influencing market growth for the medical aesthetic market. The major driving force behind the medical aesthetic market is an increase in the geriatric population. Another reason driving the growth of the market is the increasing need for accurate, and minimally invasive solutions. With customers becoming highly attuned to non-invasive alternatives, demand for modern and efficient aesthetic solutions, including multifunctional lasers and skin rejuvenation technologies, has seen a significant increase.
- Product Development/Innovation: Advanced technologies, R&D activities, and product launches in the medical aesthetics market.
- Market Development: This report will further present the regional expansion of the medical aesthetics market, focusing on the various emerging market opportunities worldwide.
- Market Diversification: The market is increasingly diversifying due to the development of innovative products, previously untapped markets, and new trends; in addition, because of significant investments in the medical aesthetics industry, contribute to its growth as well as the constant change.
- Competitive Analysis: Exhaustive study of market share, and service offering leading strategies of major players such as AbbVie Inc (US), Alma Lasers (Israel), Cynosure (US), and GALDERMA (Switzerland), among others.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Indicative list of secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
2.3 MARKET FORECASTING MODEL
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MEDICAL AESTHETICS MARKET OVERVIEW
4.2 MEDICAL AESTHETICS MARKET, BY PRODUCT
4.3 ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY END USER, 2023 (USD MILLION)
4.4 REGIONAL SNAPSHOT OF MEDICAL AESTHETICS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of minimally invasive and non-invasive
aesthetic procedures
5.2.1.2 Growing demand for aesthetic treatments among elderly and men
5.2.1.3 Rising influence of social media
5.2.2 RESTRAINTS
5.2.2.1 Risk of infection and safety concerns
5.2.2.2 Complex regulatory framework and compliance standards
5.2.3 OPPORTUNITIES
5.2.3.1 Significant opportunities in emerging economies
5.2.3.2 Launch of new technologies and products
5.2.4 CHALLENGES
5.2.4.1 High cost of treatments and devices
5.2.4.2 Social and cultural barriers
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE, BY PRODUCT (ENERGY-BASED DEVICES), 2023
5.4.2 AVERAGE SELLING PRICE OF INJECTABLES, BY TYPE, 2021–2023
5.4.3 AVERAGE SELLING PRICE OF ENERGY-BASED DEVICES, BY KEY PLAYER, 2023
5.4.4 AVERAGE SELLING PRICE TREND OF ENERGY-BASED DEVICES,
BY REGION, 2021–2023
5.5 VALUE CHAIN ANALYSIS
5.5.1 R&D
5.5.2 RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.5.4 AFTERMARKET SERVICES
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Laser and light-based technologies
5.9.1.2 Radiofrequency technology
5.9.1.3 Ultrasound technology
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 AI-powered skin analysis systems
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Regenerative medicine and stem cell therapy
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA
5.11.1.1 Import scenario for HS code 854370
5.11.1.2 Import scenario for HS code 901320
5.11.2 EXPORT DATA
5.11.2.1 Export scenario for HS code 854370
5.11.2.2 Export scenario for HS code 901320
5.12 KEY CONFERENCES AND EVENTS, 2025–2026
5.13 CASE STUDY ANALYSIS
5.13.1 COMMERCIAL PARTNERSHIPS FOR MEDICAL AESTHETIC PRODUCT SALES
5.13.2 DIVISION OF BUSINESS TO MEET CUSTOMER DEMANDS
5.13.3 COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES
5.14 REGULATORY LANDSCAPE
5.14.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.2 KEY REGULATORY GUIDELINES
5.14.2.1 North America
5.14.2.1.1 US
5.14.2.1.2 Canada
5.14.2.2 Europe
5.14.2.2.1 UK
5.14.2.2.2 France
5.14.2.2.3 Germany
5.14.2.3 Asia Pacific
5.14.2.3.1 China
5.14.2.3.2 Japan
5.14.2.3.3 India
5.14.2.4 Latin America
5.14.2.4.1 Brazil
5.14.2.5 Middle East & Africa
5.14.2.5.1 UAE
5.14.3 REGULATORY APPROVALS
5.15 PORTER’S FIVE FORCE ANALYSIS
5.15.1 THREAT OF NEW ENTRANTS
5.15.2 THREAT OF SUBSTITUTES
5.15.3 BARGAINING POWER OF SUPPLIERS
5.15.4 BARGAINING POWER OF BUYERS
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA
5.17 UNMET NEEDS
5.18 IMPACT OF AI/GEN AI ON MEDICAL AESTHETICS MARKET
5.18.1 INTRODUCTION
5.18.2 MARKET POTENTIAL OF AI IN MEDICAL AESTHETIC APPLICATIONS
5.18.3 AI USE CASES
5.18.4 KEY COMPANIES IMPLEMENTING AI
5.18.5 FUTURE OF AI/GEN AI IN MEDICAL AESTHETICS ECOSYSTEM
6 MEDICAL AESTHETICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 FACIAL AESTHETIC PRODUCTS
6.2.1 BOTULINUM TOXIN
6.2.1.1 Growing willingness for Botox process to boost market
6.2.2 DERMAL FILLERS
6.2.2.1 Natural dermal fillers
6.2.2.1.1 Rising use of dermal fillers in facial contouring to support growth
6.2.2.2 Synthetic dermal fillers
6.2.2.2.1 Need for quick aesthetic enhancements to accelerate growth
6.2.3 CHEMICAL PEELS
6.2.3.1 Increasing availability of wide range of chemical peels to expedite growth
6.2.4 MICRODERMABRASION
6.2.4.1 Growing use of low-risk and cost-effective resurfacing methods to fuel market
6.3 BODY CONTOURING DEVICES
6.3.1 NON-SURGICAL FAT REDUCTION DEVICES
6.3.1.1 Rise in obesity cases to sustain growth
6.3.2 CELLULITE REDUCTION DEVICES
6.3.2.1 Increasing focus on appearances to fuel market
6.3.3 LIPOSUCTION DEVICES
6.3.3.1 Growing awareness about obesity-related health risks to propel market
6.4 COSMETIC IMPLANTS
6.4.1 BREAST IMPLANTS
6.4.1.1 Silicone breast implants
6.4.1.1.1 Increasing number of promotional efforts and new products by leading companies to aid growth
6.4.1.2 Saline breast implants
6.4.1.2.1 Reduced cost of breast implants to support growth
6.4.2 FACIAL IMPLANTS
6.4.2.1 Growing awareness about benefits of facial implants over other contouring products to drive market
6.4.3 OTHER IMPLANTS
6.5 PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS
6.5.1 ONGOING SHIFT TOWARD DEVELOPING SAFER SKIN-LIGHTENING PRODUCTS TO FAVOR GROWTH
6.6 SKIN AESTHETIC DEVICES
6.6.1 LASER SKIN RESURFACING DEVICES
6.6.1.1 Booming geriatric population to support growth
6.6.2 NON-SURGICAL SKIN TIGHTENING DEVICES
6.6.2.1 Rising popularity of non-invasive methods to speed up growth
6.6.3 MICRONEEDLING PRODUCTS
6.6.3.1 Reduced discomfort and enhanced skin rejuvenation to augment growth
6.6.4 LIGHT THERAPY DEVICES
6.6.4.1 Growing use of light therapy for pain management and sleep regulation to boost market
6.7 PHYSICIAN-DISPENSED EYELASH PRODUCTS
6.7.1 EXPANDING MIDDLE CLASS POPULATION TO ENCOURAGE GROWTH
6.8 HAIR REMOVAL DEVICES
6.8.1 LASER HAIR REMOVAL DEVICES
6.8.1.1 Increasing availability of user-friendly home-use laser devices
to spur growth
6.8.2 IPL HAIR REMOVAL DEVICES
6.8.2.1 Growing interest in cosmetic treatments to fuel market
6.9 TATTOO REMOVAL DEVICES
6.9.1 NEED FOR MINIMIZED SKIN DAMAGE TO FAVOR GROWTH
6.10 THREAD LIFT PRODUCTS
6.10.1 RISING PREFERENCE FOR MINIMAL RECOVERY TIME AND QUICK RESULTS TO STIMULATE GROWTH
6.11 NAIL TREATMENT LASER DEVICES
6.11.1 INCREASING DEMAND FOR QUICK AND PAINLESS PROCEDURE TO PROMOTE GROWTH
6.12 HOME CARE DEVICES
6.12.1 GROWING DEMAND FOR AFFORDABLE AND CONVENIENT HOME-BASED TREATMENTS TO DRIVE MARKET
7 MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE
7.1 INTRODUCTION
7.2 STANDALONE DEVICES
7.2.1 INCREASING INNOVATIONS IN ENERGY-BASED TECHNOLOGIES TO DRIVE MARKET
7.3 MULTIMODAL DEVICES
7.3.1 GROWING AVAILABILITY OF PERSONALIZED CARE AND TAILORED TREATMENT TO PROPEL MARKET
7.4 AT-HOME/SELF-USE DEVICES
7.4.1 RISING FOCUS ON ENHANCED SKIN HEALTH TO FACILITATE GROWTH
8 MEDICAL AESTHETICS MARKET, BY PROCEDURE
8.1 INTRODUCTION
8.2 NON-SURGICAL PROCEDURES
8.2.1 ANTI-AGING AND SKIN REJUVENATION
8.2.1.1 Rising preference for maintaining youthful appearance to promote growth
8.2.2 TATTOO REMOVAL
8.2.2.1 Increased accessibility to tattoo removal processes to facilitate growth
8.2.3 HAIR REMOVAL
8.2.3.1 Growing adherence to conventional beauty standards to drive market
8.2.4 LIPOSUCTION
8.2.4.1 Increased dominance of sedentary lifestyles to encourage growth
8.2.5 OTHER NON-SURGICAL PROCEDURES
8.3 SURGICAL PROCEDURES
8.3.1 BREAST IMPLANTS
8.3.1.1 Changing aesthetic preferences to drive market
8.3.2 FACELIFT & BODY LIFT PROCEDURES
8.3.2.1 Increasing need to reduce visible signs of aging to expedite growth
8.3.3 OTHER SURGICAL PROCEDURES
9 MEDICAL AESTHETICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 CLINICS, HOSPITALS, AND MEDICAL SPAS
9.2.1 RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY
TO ENCOURAGE GROWTH
9.3 BEAUTY CENTERS
9.3.1 GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO BOOST MARKET
9.4 HOME CARE SETTINGS
9.4.1 INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY,
AND COST SAVING TO SPUR GROWTH
10 MEDICAL AESTHETICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Growing adoption of advanced treatment procedures to drive market
10.2.3 CANADA
10.2.3.1 Increasing preference among aging individuals for physical rejuvenation to aid growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Rising social acceptance of medical aesthetic procedures
to stimulate growth
10.3.3 UK
10.3.3.1 Booming cosmetics and beauty industry to accelerate growth
10.3.4 FRANCE
10.3.4.1 Growing social acceptance of medical aesthetic treatments to fuel market
10.3.5 ITALY
10.3.5.1 Growing adoption of surgical procedures among young females
to boost market
10.3.6 SPAIN
10.3.6.1 Increasing availability of safe and minimally invasive treatments
to augment growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rising awareness for body contouring treatments to sustain growth
10.4.3 CHINA
10.4.3.1 Increased availability of cosmetic surgery apps and online services to aid growth
10.4.4 INDIA
10.4.4.1 Increasing disposable incomes to contribute to market growth
10.4.5 AUSTRALIA
10.4.5.1 Favorable government initiatives to promote growth
10.4.6 SOUTH KOREA
10.4.6.1 Booming medical tourism to speed up growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Expanding target population base to expedite growth
10.5.3 MEXICO
10.5.3.1 Increasing inflow of medical tourists to favor growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Favorable government policies to propel market.
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL
AESTHETICS MARKET
11.3 REVENUE ANALYSIS, 2020–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 ENERGY-BASED AESTHETIC DEVICES MARKET
11.4.2 FACIAL AESTHETIC PRODUCTS MARKET
11.4.3 COSMETIC IMPLANTS MARKET
11.5 RANKING OF KEY MARKET PLAYERS
11.6 COMPANY EVALUATION MATRIX, 2023
11.6.1 ENERGY-BASED AESTHETIC DEVICES MARKET
11.6.1.1 Stars
11.6.1.2 Emerging leaders
11.6.1.3 Pervasive players
11.6.1.4 Participants
11.6.2 FACIAL AESTHETIC PRODUCTS MARKET
11.6.2.1 Stars
11.6.2.2 Emerging leaders
11.6.2.3 Pervasive players
11.6.2.4 Participants
11.6.3 COSMETIC IMPLANTS MARKET
11.6.3.1 Stars
11.6.3.2 Emerging leaders
11.6.3.3 Pervasive players
11.6.3.4 Participants
11.6.4 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.6.4.1 Company footprint
11.6.4.2 Region footprint
11.6.4.3 Product footprint
11.6.4.4 Type of device footprint
11.6.4.5 Procedure footprint
11.6.4.6 End-user footprint
11.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of startups/SMEs
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 ABBVIE INC.
12.1.1.1 Business overview
12.1.1.2 Products/Solutions offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches and approvals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 GALDERMA
12.1.2.1 Business overview
12.1.2.2 Products/Solutions offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches and approvals
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 JOHNSON & JOHNSON SERVICES, INC.
12.1.3.1 Business overview
12.1.3.2 Products/Solutions offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches and approvals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 BAUSCH HEALTH COMPANIES INC.
12.1.4.1 Business overview
12.1.4.2 Products/Solutions offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches and approvals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 CYNOSURE LUTRONIC
12.1.5.1 Business overview
12.1.5.2 Products/Solutions offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches and approvals
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 CUTERA, INC.
12.1.6.1 Business overview
12.1.6.2 Products/Solutions offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches and approvals
12.1.6.3.2 Deals
12.1.7 MERZ PHARMA
12.1.7.1 Business overview
12.1.7.2 Products/Solutions offered
12.1.7.3 Recent developments
12.1.7.3.1 Expansions
12.1.8 LUMENIS BE LTD.
12.1.8.1 Business overview
12.1.8.2 Products/Solutions offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches and approvals
12.1.8.3.2 Deals
12.1.9 FOTONA
12.1.9.1 Business overview
12.1.9.2 Products/Solutions offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches and approvals
12.1.9.3.2 Expansions
12.1.10 AEROLASE CORP.
12.1.10.1 Business overview
12.1.10.2 Products/Solutions offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches and approvals
12.1.11 SCITON
12.1.11.1 Business overview
12.1.11.2 Products/Solutions offered
12.1.11.3 Recent developments
12.1.11.3.1 Product launches and approvals
12.1.12 BOHUS BIOTECH AB
12.1.12.1 Business overview
12.1.12.2 Products/Solutions offered
12.1.13 RECOSMO
12.1.13.1 Business overview
12.1.13.2 Products/Solutions offered
12.1.14 SHARPLIGHT TECHNOLOGIES INC.
12.1.14.1 Business overview
12.1.14.2 Products/Solutions offered
12.1.14.3 Recent developments
12.1.14.3.1 Product launches and approvals
12.1.15 CANDELA CORPORATION
12.1.15.1 Business overview
12.1.15.2 Products/Solutions offered
12.1.15.3 Recent developments
12.1.15.3.1 Product launches and approvals
12.1.15.3.2 Deals
12.1.16 ALMA LASERS
12.1.16.1 Business overview
12.1.16.2 Products/Solutions offered
12.1.16.3 Recent developments
12.1.16.3.1 Product launches and approvals
12.1.16.3.2 Deals
12.1.17 EL.EN. S.P.A.
12.1.17.1 Business overview
12.1.17.2 Products/Solutions offered
12.1.17.3 Recent developments
12.1.17.3.1 Product launches and approvals
12.1.18 INMODE LTD.
12.1.18.1 Business overview
12.1.18.2 Products/Solutions offered
12.1.18.3 Recent developments
12.1.18.3.1 Product launches and approvals
12.1.19 VENUS CONCEPT
12.1.19.1 Business overview
12.1.19.2 Products/Solutions offered
12.1.19.3 Recent developments
12.1.19.3.1 Product launches and approvals
12.1.20 GC AESTHETICS
12.1.20.1 Business overview
12.1.20.2 Products/Solutions offered
12.1.20.3 Recent developments
12.1.20.3.1 Product launches and approvals
12.1.20.3.2 Deals
12.2 OTHER COMPANIES
12.2.1 EVOLUS, INC.
12.2.2 ASCLEPION LASER TECHNOLOGIES
12.2.3 ASTANZA LASER
12.2.4 APYX MEDICAL
12.2.5 HUADONG MEDICINE CO., LTD.
12.2.6 MEDYTOX INC.
12.2.7 POLYTECH HEALTH & AESTHETICS GMBH
12.2.8 REVANCE AESTHETICS
12.2.9 PHOTOMEDEX
12.2.10 2L BIO CO., LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Indicative list of secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
2.3 MARKET FORECASTING MODEL
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MEDICAL AESTHETICS MARKET OVERVIEW
4.2 MEDICAL AESTHETICS MARKET, BY PRODUCT
4.3 ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY END USER, 2023 (USD MILLION)
4.4 REGIONAL SNAPSHOT OF MEDICAL AESTHETICS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of minimally invasive and non-invasive
aesthetic procedures
5.2.1.2 Growing demand for aesthetic treatments among elderly and men
5.2.1.3 Rising influence of social media
5.2.2 RESTRAINTS
5.2.2.1 Risk of infection and safety concerns
5.2.2.2 Complex regulatory framework and compliance standards
5.2.3 OPPORTUNITIES
5.2.3.1 Significant opportunities in emerging economies
5.2.3.2 Launch of new technologies and products
5.2.4 CHALLENGES
5.2.4.1 High cost of treatments and devices
5.2.4.2 Social and cultural barriers
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE, BY PRODUCT (ENERGY-BASED DEVICES), 2023
5.4.2 AVERAGE SELLING PRICE OF INJECTABLES, BY TYPE, 2021–2023
5.4.3 AVERAGE SELLING PRICE OF ENERGY-BASED DEVICES, BY KEY PLAYER, 2023
5.4.4 AVERAGE SELLING PRICE TREND OF ENERGY-BASED DEVICES,
BY REGION, 2021–2023
5.5 VALUE CHAIN ANALYSIS
5.5.1 R&D
5.5.2 RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.5.4 AFTERMARKET SERVICES
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Laser and light-based technologies
5.9.1.2 Radiofrequency technology
5.9.1.3 Ultrasound technology
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 AI-powered skin analysis systems
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Regenerative medicine and stem cell therapy
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA
5.11.1.1 Import scenario for HS code 854370
5.11.1.2 Import scenario for HS code 901320
5.11.2 EXPORT DATA
5.11.2.1 Export scenario for HS code 854370
5.11.2.2 Export scenario for HS code 901320
5.12 KEY CONFERENCES AND EVENTS, 2025–2026
5.13 CASE STUDY ANALYSIS
5.13.1 COMMERCIAL PARTNERSHIPS FOR MEDICAL AESTHETIC PRODUCT SALES
5.13.2 DIVISION OF BUSINESS TO MEET CUSTOMER DEMANDS
5.13.3 COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES
5.14 REGULATORY LANDSCAPE
5.14.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.2 KEY REGULATORY GUIDELINES
5.14.2.1 North America
5.14.2.1.1 US
5.14.2.1.2 Canada
5.14.2.2 Europe
5.14.2.2.1 UK
5.14.2.2.2 France
5.14.2.2.3 Germany
5.14.2.3 Asia Pacific
5.14.2.3.1 China
5.14.2.3.2 Japan
5.14.2.3.3 India
5.14.2.4 Latin America
5.14.2.4.1 Brazil
5.14.2.5 Middle East & Africa
5.14.2.5.1 UAE
5.14.3 REGULATORY APPROVALS
5.15 PORTER’S FIVE FORCE ANALYSIS
5.15.1 THREAT OF NEW ENTRANTS
5.15.2 THREAT OF SUBSTITUTES
5.15.3 BARGAINING POWER OF SUPPLIERS
5.15.4 BARGAINING POWER OF BUYERS
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA
5.17 UNMET NEEDS
5.18 IMPACT OF AI/GEN AI ON MEDICAL AESTHETICS MARKET
5.18.1 INTRODUCTION
5.18.2 MARKET POTENTIAL OF AI IN MEDICAL AESTHETIC APPLICATIONS
5.18.3 AI USE CASES
5.18.4 KEY COMPANIES IMPLEMENTING AI
5.18.5 FUTURE OF AI/GEN AI IN MEDICAL AESTHETICS ECOSYSTEM
6 MEDICAL AESTHETICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 FACIAL AESTHETIC PRODUCTS
6.2.1 BOTULINUM TOXIN
6.2.1.1 Growing willingness for Botox process to boost market
6.2.2 DERMAL FILLERS
6.2.2.1 Natural dermal fillers
6.2.2.1.1 Rising use of dermal fillers in facial contouring to support growth
6.2.2.2 Synthetic dermal fillers
6.2.2.2.1 Need for quick aesthetic enhancements to accelerate growth
6.2.3 CHEMICAL PEELS
6.2.3.1 Increasing availability of wide range of chemical peels to expedite growth
6.2.4 MICRODERMABRASION
6.2.4.1 Growing use of low-risk and cost-effective resurfacing methods to fuel market
6.3 BODY CONTOURING DEVICES
6.3.1 NON-SURGICAL FAT REDUCTION DEVICES
6.3.1.1 Rise in obesity cases to sustain growth
6.3.2 CELLULITE REDUCTION DEVICES
6.3.2.1 Increasing focus on appearances to fuel market
6.3.3 LIPOSUCTION DEVICES
6.3.3.1 Growing awareness about obesity-related health risks to propel market
6.4 COSMETIC IMPLANTS
6.4.1 BREAST IMPLANTS
6.4.1.1 Silicone breast implants
6.4.1.1.1 Increasing number of promotional efforts and new products by leading companies to aid growth
6.4.1.2 Saline breast implants
6.4.1.2.1 Reduced cost of breast implants to support growth
6.4.2 FACIAL IMPLANTS
6.4.2.1 Growing awareness about benefits of facial implants over other contouring products to drive market
6.4.3 OTHER IMPLANTS
6.5 PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS
6.5.1 ONGOING SHIFT TOWARD DEVELOPING SAFER SKIN-LIGHTENING PRODUCTS TO FAVOR GROWTH
6.6 SKIN AESTHETIC DEVICES
6.6.1 LASER SKIN RESURFACING DEVICES
6.6.1.1 Booming geriatric population to support growth
6.6.2 NON-SURGICAL SKIN TIGHTENING DEVICES
6.6.2.1 Rising popularity of non-invasive methods to speed up growth
6.6.3 MICRONEEDLING PRODUCTS
6.6.3.1 Reduced discomfort and enhanced skin rejuvenation to augment growth
6.6.4 LIGHT THERAPY DEVICES
6.6.4.1 Growing use of light therapy for pain management and sleep regulation to boost market
6.7 PHYSICIAN-DISPENSED EYELASH PRODUCTS
6.7.1 EXPANDING MIDDLE CLASS POPULATION TO ENCOURAGE GROWTH
6.8 HAIR REMOVAL DEVICES
6.8.1 LASER HAIR REMOVAL DEVICES
6.8.1.1 Increasing availability of user-friendly home-use laser devices
to spur growth
6.8.2 IPL HAIR REMOVAL DEVICES
6.8.2.1 Growing interest in cosmetic treatments to fuel market
6.9 TATTOO REMOVAL DEVICES
6.9.1 NEED FOR MINIMIZED SKIN DAMAGE TO FAVOR GROWTH
6.10 THREAD LIFT PRODUCTS
6.10.1 RISING PREFERENCE FOR MINIMAL RECOVERY TIME AND QUICK RESULTS TO STIMULATE GROWTH
6.11 NAIL TREATMENT LASER DEVICES
6.11.1 INCREASING DEMAND FOR QUICK AND PAINLESS PROCEDURE TO PROMOTE GROWTH
6.12 HOME CARE DEVICES
6.12.1 GROWING DEMAND FOR AFFORDABLE AND CONVENIENT HOME-BASED TREATMENTS TO DRIVE MARKET
7 MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE
7.1 INTRODUCTION
7.2 STANDALONE DEVICES
7.2.1 INCREASING INNOVATIONS IN ENERGY-BASED TECHNOLOGIES TO DRIVE MARKET
7.3 MULTIMODAL DEVICES
7.3.1 GROWING AVAILABILITY OF PERSONALIZED CARE AND TAILORED TREATMENT TO PROPEL MARKET
7.4 AT-HOME/SELF-USE DEVICES
7.4.1 RISING FOCUS ON ENHANCED SKIN HEALTH TO FACILITATE GROWTH
8 MEDICAL AESTHETICS MARKET, BY PROCEDURE
8.1 INTRODUCTION
8.2 NON-SURGICAL PROCEDURES
8.2.1 ANTI-AGING AND SKIN REJUVENATION
8.2.1.1 Rising preference for maintaining youthful appearance to promote growth
8.2.2 TATTOO REMOVAL
8.2.2.1 Increased accessibility to tattoo removal processes to facilitate growth
8.2.3 HAIR REMOVAL
8.2.3.1 Growing adherence to conventional beauty standards to drive market
8.2.4 LIPOSUCTION
8.2.4.1 Increased dominance of sedentary lifestyles to encourage growth
8.2.5 OTHER NON-SURGICAL PROCEDURES
8.3 SURGICAL PROCEDURES
8.3.1 BREAST IMPLANTS
8.3.1.1 Changing aesthetic preferences to drive market
8.3.2 FACELIFT & BODY LIFT PROCEDURES
8.3.2.1 Increasing need to reduce visible signs of aging to expedite growth
8.3.3 OTHER SURGICAL PROCEDURES
9 MEDICAL AESTHETICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 CLINICS, HOSPITALS, AND MEDICAL SPAS
9.2.1 RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY
TO ENCOURAGE GROWTH
9.3 BEAUTY CENTERS
9.3.1 GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO BOOST MARKET
9.4 HOME CARE SETTINGS
9.4.1 INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY,
AND COST SAVING TO SPUR GROWTH
10 MEDICAL AESTHETICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Growing adoption of advanced treatment procedures to drive market
10.2.3 CANADA
10.2.3.1 Increasing preference among aging individuals for physical rejuvenation to aid growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Rising social acceptance of medical aesthetic procedures
to stimulate growth
10.3.3 UK
10.3.3.1 Booming cosmetics and beauty industry to accelerate growth
10.3.4 FRANCE
10.3.4.1 Growing social acceptance of medical aesthetic treatments to fuel market
10.3.5 ITALY
10.3.5.1 Growing adoption of surgical procedures among young females
to boost market
10.3.6 SPAIN
10.3.6.1 Increasing availability of safe and minimally invasive treatments
to augment growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Rising awareness for body contouring treatments to sustain growth
10.4.3 CHINA
10.4.3.1 Increased availability of cosmetic surgery apps and online services to aid growth
10.4.4 INDIA
10.4.4.1 Increasing disposable incomes to contribute to market growth
10.4.5 AUSTRALIA
10.4.5.1 Favorable government initiatives to promote growth
10.4.6 SOUTH KOREA
10.4.6.1 Booming medical tourism to speed up growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Expanding target population base to expedite growth
10.5.3 MEXICO
10.5.3.1 Increasing inflow of medical tourists to favor growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Favorable government policies to propel market.
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL
AESTHETICS MARKET
11.3 REVENUE ANALYSIS, 2020–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 ENERGY-BASED AESTHETIC DEVICES MARKET
11.4.2 FACIAL AESTHETIC PRODUCTS MARKET
11.4.3 COSMETIC IMPLANTS MARKET
11.5 RANKING OF KEY MARKET PLAYERS
11.6 COMPANY EVALUATION MATRIX, 2023
11.6.1 ENERGY-BASED AESTHETIC DEVICES MARKET
11.6.1.1 Stars
11.6.1.2 Emerging leaders
11.6.1.3 Pervasive players
11.6.1.4 Participants
11.6.2 FACIAL AESTHETIC PRODUCTS MARKET
11.6.2.1 Stars
11.6.2.2 Emerging leaders
11.6.2.3 Pervasive players
11.6.2.4 Participants
11.6.3 COSMETIC IMPLANTS MARKET
11.6.3.1 Stars
11.6.3.2 Emerging leaders
11.6.3.3 Pervasive players
11.6.3.4 Participants
11.6.4 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.6.4.1 Company footprint
11.6.4.2 Region footprint
11.6.4.3 Product footprint
11.6.4.4 Type of device footprint
11.6.4.5 Procedure footprint
11.6.4.6 End-user footprint
11.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of startups/SMEs
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 ABBVIE INC.
12.1.1.1 Business overview
12.1.1.2 Products/Solutions offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches and approvals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 GALDERMA
12.1.2.1 Business overview
12.1.2.2 Products/Solutions offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches and approvals
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 JOHNSON & JOHNSON SERVICES, INC.
12.1.3.1 Business overview
12.1.3.2 Products/Solutions offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches and approvals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 BAUSCH HEALTH COMPANIES INC.
12.1.4.1 Business overview
12.1.4.2 Products/Solutions offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches and approvals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 CYNOSURE LUTRONIC
12.1.5.1 Business overview
12.1.5.2 Products/Solutions offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches and approvals
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 CUTERA, INC.
12.1.6.1 Business overview
12.1.6.2 Products/Solutions offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches and approvals
12.1.6.3.2 Deals
12.1.7 MERZ PHARMA
12.1.7.1 Business overview
12.1.7.2 Products/Solutions offered
12.1.7.3 Recent developments
12.1.7.3.1 Expansions
12.1.8 LUMENIS BE LTD.
12.1.8.1 Business overview
12.1.8.2 Products/Solutions offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches and approvals
12.1.8.3.2 Deals
12.1.9 FOTONA
12.1.9.1 Business overview
12.1.9.2 Products/Solutions offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches and approvals
12.1.9.3.2 Expansions
12.1.10 AEROLASE CORP.
12.1.10.1 Business overview
12.1.10.2 Products/Solutions offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches and approvals
12.1.11 SCITON
12.1.11.1 Business overview
12.1.11.2 Products/Solutions offered
12.1.11.3 Recent developments
12.1.11.3.1 Product launches and approvals
12.1.12 BOHUS BIOTECH AB
12.1.12.1 Business overview
12.1.12.2 Products/Solutions offered
12.1.13 RECOSMO
12.1.13.1 Business overview
12.1.13.2 Products/Solutions offered
12.1.14 SHARPLIGHT TECHNOLOGIES INC.
12.1.14.1 Business overview
12.1.14.2 Products/Solutions offered
12.1.14.3 Recent developments
12.1.14.3.1 Product launches and approvals
12.1.15 CANDELA CORPORATION
12.1.15.1 Business overview
12.1.15.2 Products/Solutions offered
12.1.15.3 Recent developments
12.1.15.3.1 Product launches and approvals
12.1.15.3.2 Deals
12.1.16 ALMA LASERS
12.1.16.1 Business overview
12.1.16.2 Products/Solutions offered
12.1.16.3 Recent developments
12.1.16.3.1 Product launches and approvals
12.1.16.3.2 Deals
12.1.17 EL.EN. S.P.A.
12.1.17.1 Business overview
12.1.17.2 Products/Solutions offered
12.1.17.3 Recent developments
12.1.17.3.1 Product launches and approvals
12.1.18 INMODE LTD.
12.1.18.1 Business overview
12.1.18.2 Products/Solutions offered
12.1.18.3 Recent developments
12.1.18.3.1 Product launches and approvals
12.1.19 VENUS CONCEPT
12.1.19.1 Business overview
12.1.19.2 Products/Solutions offered
12.1.19.3 Recent developments
12.1.19.3.1 Product launches and approvals
12.1.20 GC AESTHETICS
12.1.20.1 Business overview
12.1.20.2 Products/Solutions offered
12.1.20.3 Recent developments
12.1.20.3.1 Product launches and approvals
12.1.20.3.2 Deals
12.2 OTHER COMPANIES
12.2.1 EVOLUS, INC.
12.2.2 ASCLEPION LASER TECHNOLOGIES
12.2.3 ASTANZA LASER
12.2.4 APYX MEDICAL
12.2.5 HUADONG MEDICINE CO., LTD.
12.2.6 MEDYTOX INC.
12.2.7 POLYTECH HEALTH & AESTHETICS GMBH
12.2.8 REVANCE AESTHETICS
12.2.9 PHOTOMEDEX
12.2.10 2L BIO CO., LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
